Cyclic AMP, Urine

Test ID: 


CPT code:



cAMP, Urine

Clinical Use:

Differential diagnosis of hyperparathyroidism. In hyperparathyroidism there is increased cAMP in urine. Increased levels are also found in humoral hypercalcemia of malignancy and vitamin D deficiency. The plasma concentrations of immunoreactive parathyroid hormone-related protein correlate with levels of excreted cyclic AMP.

Test Information:

There is a role for cAMP excretion measurement in the evaluation of Zollinger-Ellison syndrome and differentiation of sporadic cases from those of multiple endocrine neoplasia type I.2 Assay of nephrogenous cyclic AMP has been applied to the monitoring of calcium intake in cases of osteoporosis.
A target of parathyroid hormone (PTH) action is the renal tubule. The result is release of cAMP into the urine. Cyclic AMP output in the urine is thus an indirect measure of parathyroid action. PTH utilizes cyclic AMP to exert its effect on cells. Upon binding of PTH to its receptor, the latter undergoes a confirmational change which increases its affinity (through a second binding site) for a linking protein (Ns) which also binds guanosine triphosphate.
Type I pseudohypoparathyroidism (autosomal dominant inheritance), mimics hypoparathyroidism with hypocalcemia resistant to vitamin D and high serum phosphate and PTH levels. This condition appears to be due to a defect in linking protein (Ns) structure. Type I is characterized by defective renal tubular response to PTH and increased circulating and urinary cyclic AMP. Type II pseudohypoparathyroidism (autosomal dominant inheritance) has a normal cyclic AMP response.
The level of urinary cAMP is the result of cAMP released by PTH, action of other hormones and plasma cAMP filtered by the renal glomerulus. “Nephrogenous cAMP” is the urinary excretion of cAMP minus that filtered by the glomerulus and correlates best with the results of plasma PTH levels.

Specimen Type:

Urine (random), frozen

Requested Volume: 

10 mL

Minimum Volume: 

0.5 mL

Container Type: 

Transport tube

Patient Preparation: 

PTH or ADH may be administered as a provocative test. No isotopes administered 48 hours prior to and during collection.


Transfer the urine into a PP transpak frozen purple tube with screw cap. Freeze immediately and maintain frozen until tested.

Storage Instructions:


Stability Requirements:




14 days

Freeze/thaw cycles

Stable x3

Rejection Criteria

Specimen not received frozen; recently administered radioisotopes

Return Back to Test Directory

MCI Diagnostic

Providing top patient care with fast results. 

7018 South Utica Avenue

Tulsa, Oklahoma 74136

Hours of Operation

Mon – Sat: 7AM-11PM

Sun: 7AM-3PM

Government Contract

Mon – Sat: 7AM-11PM

Sun: 7AM-3PM


Mon – Sat: 7AM-11PM

Sun: 7AM-3PM

Thank you for uploading your files. Your upload has been submitted successfully.